Biotech Stocks Continue to Offer Huge Returns for Investors
Companies / BioTech Dec 06, 2015 - 11:41 AM GMTBy: Investment_U
Rachel Gearhart writes: Earlier this year, we argued investors should snatch up biotech bargains while they were hot.
And, boy, were we right.
This week’s chart looks at the performance of the NYSE Arca Biotechnology Index (NYSE: BTK) and the S&P 500 since the beginning of the year.
As you can see, the biotech sector dropped more than 20% in August. It then made a solid 14% recovery before dropping again in September.
Since then, biotech is up more than 15%.
It all goes to support our thesis that big drops in this volatile sector are typically followed by even bigger uptrends.
Now, biotech stocks certainly come with their fair share of risks. But investors have a better chance of quickly generating huge returns here than in the broader market.
In fact, so far this year the S&P 500 has struggled to stay positive. It’s averaged only a 0.8% return. Compare that to the average 9.5% return from the biotech index.
Over the past 20 years, the healthcare sector as a whole has had one of the highest annualized gains of any other asset class... more than 12%.
And it’s showing no sign of letting up.
If you heeded our advice and grabbed some bargain biotech stocks, you likely turned a nice profit. If you didn’t, don’t worry. There are still plenty of opportunities ahead.
Recently, The Oxford Club’s No. 1 biotech enthusiast Marc Lichtenfeld identified what has the potential to be a $230 billion trend in the sector. This discovery not only could save your life, but also could make you a fortune.
That’s why, on Wednesday, December 9, we’re hosting a free online event, titled “SuperBugs, SuperCures, SuperProfits: How to Make a Fortune From the $230 Billion Microbiome Revolution.”
Not only will this special event feature Marc, but you’ll also hear from renowned gastroenterologist and assistant professor at Georgetown University Hospital Dr. Robynne Chutkan... plus Jenny Thompson, director of the Health Sciences Institute.
To see more details and register for free, simply click here.
Copyright © 1999 - 2015 by The Oxford Club, L.L.C All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Investment U, Attn: Member Services , 105 West Monument Street, Baltimore, MD 21201 Email: CustomerService@InvestmentU.com
Disclaimer: Investment U Disclaimer: Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.
